Occurrence of dermatomycoses and in-vitro therapeutic efficacy of three antifungal drugs on the growth of Epidermophyton floccosum

Mycopathologia

Volumn 156, Issue 4, 2003, Pages 295-301

  Awoderu, V A ^a   Nebo, G G ^a   Otudero, V O ^a  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

Author keywords

Antifungal drugs; E. floccosum; Fungistatic and fungicidal effects

Indexed keywords

ANTIFUNGAL AGENT; GRISEOFULVIN; KETOCONAZOLE; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ARTICLE; CHILD; DRUG EFFECT; EPIDERMOPHYTON; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NIGERIA; PREVALENCE; TINEA;

ANTIFUNGAL AGENTS; CHILD; EPIDERMOPHYTON; FEMALE; GRISEOFULVIN; HUMANS; KETOCONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; NIGERIA; PREVALENCE; TINEA;

ARTHRODERMATACEAE; CANIS; EPIDERMOPHYTON FLOCCOSUM; MICROSPORUM; MICROSPORUM CANIS; TINEA; TRICHOPHYTON; TRICHOPHYTON TONSURANS;

EID: 0344736787     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MYCO.0000003556.59951.bf     Document Type: Article

References (17)

1. Arzeni D, Baarchies F, Compagnucci P, Cellini A, Simonetti O, Offidani AM, Scalise G. In-vitrv activity of terbinafine against clinical isolates of dermatophytes. 4th ed. Italy, 1998: 235-242.
2. Butty P, Mellie M, Bastide JM. Antifungal activity of allylamines on Epidermophyton floccosum: Scanning electron microscopy study. Mycopathologia 1992; 120: 147-153.
3. Deacon JW. Introduction to modern mycology. 2nd ed. Oxford, London: Blackwell Scientific Publications, 1983: 205-211.
4. Duguid JP, Marmion BP, Swain RLI. Medical Microbiology. English Language Book Society. Unabridged edition, Edward Arnpl. Ltd. London, England. 1978: 541-553.
5. Ebadi M. Pharmacology. An illustrated review with question and explanation, 3rd ed. Boston, New York, Toronto, London: Little Brown and Company, 1996: 297-300.
6. Enweani IB, Ozan CC, Agbonlahor DE, Ndip RN. Dematomycoses in school children in Ekpoma Nigeria. Mycoses 1996(July/August); 39: 303-305.
7. Gruseck E, Splanemann V, Bleek O, King J, Abeck D. Oral terbinafine in tinea capitis in children Hamburg, Germany. Mycoses 1996; 39: 237-277.
8. Jackyk WK. Clinical experiences with canestin cream in the treatment of dermatophytes in Nigeria. Nigeria Medical Journal 1978; 8: 18.
9. Katzung BG. Pharmacology, 7th ed. Stanford, Connecticut: Appleton and Lange, 1997: 780-786.
10. Macura AB. In-vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods. Int. J. Dermatol. 1993(July); 32: 533-536.
11. Okoro AN. Skin diseases in Nigeria Trans. St. John's Hospital Derm. Society 1973; 58(1): 68 (Abstract).
12. Ogbonna CIC, Robinson RO, Abubakar M. The distribution of ringworm infections among primary school children in José Plateau State, Nigeria. Mycopathologia 1985; 89: 101-106.
13. Pelezar MJ, Chan FC, Noel RK. Microbiology concepts and application, 5th ed. New York, Montreal, New Delhi: McGraw Hill, Inc., 1993: 272.
14. Range HP, Dale MM, Ritter JM. Pharmacology, 3rd ed. Edinburgh, London: Churchill Livingstone, 1996: 367-381.
15. Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes, 3rd ed. Philadelphia: The W.B. Saunders Company, 1988: 169-275.
16. Somorin NF, Adetosoyc AT, Humponu W. Dermatophytes in School Children in Nigeria. Journal of Paediatric 1977; 4:49-52.
17. Weitzman I. Rosenthal SA. Silva-Hunter M. Superficial and cutaneous infections caused by moulds: dermatomycoses 1996, pp. 33-97. In Wentworth B.B. edition: Diagnostic procedure for mycotic and parasitic infection 7th ed. American Public Health Association Inc. Washington D.C.